Doxazosin mesylate
NDC 62135-053, Doxazosin mesylate, tablet, from Chartwell RX, LLC.
- Product NDC
- 62135-053
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075646
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-053 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE4 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-053-90 | 62135005390 | 90 TABLET in 1 BOTTLE (62135-053-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a7f589b0-eebb-48cb-912f-a4bd956e4dcbNADAC price for package 62135005390
GET /v1/drugs/nadac/62135005390
Use it
Look up 62135-053 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-053 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-053. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.